Incyte Corp (INCY)
51.18
-0.56
(-1.08%)
USD |
NASDAQ |
Apr 25, 16:00
51.18
0.00 (0.00%)
After-Hours: 20:00
Incyte Gross Profit (Quarterly): 943.54M for Dec. 31, 2023
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 943.54M |
September 30, 2023 | 858.92M |
June 30, 2023 | 886.31M |
March 31, 2023 | 751.87M |
December 31, 2022 | 867.50M |
September 30, 2022 | 768.70M |
June 30, 2022 | 860.80M |
March 31, 2022 | 690.64M |
December 31, 2021 | 818.96M |
September 30, 2021 | 773.09M |
June 30, 2021 | 667.71M |
March 31, 2021 | 575.52M |
December 31, 2020 | 753.21M |
September 30, 2020 | 586.34M |
June 30, 2020 | 654.64M |
March 31, 2020 | 541.21M |
December 31, 2019 | 547.14M |
September 30, 2019 | 521.58M |
June 30, 2019 | 500.53M |
March 31, 2019 | 475.27M |
December 31, 2018 | 502.04M |
September 30, 2018 | 424.89M |
June 30, 2018 | 496.66M |
March 31, 2018 | 364.18M |
December 31, 2017 | 421.80M |
Date | Value |
---|---|
September 30, 2017 | 359.50M |
June 30, 2017 | 306.18M |
March 31, 2017 | 369.26M |
December 31, 2016 | 306.89M |
September 30, 2016 | 249.26M |
June 30, 2016 | 233.92M |
March 31, 2016 | 257.46M |
December 31, 2015 | 234.15M |
September 30, 2015 | 179.57M |
June 30, 2015 | 156.73M |
March 31, 2015 | 156.30M |
December 31, 2014 | 121.54M |
September 30, 2014 | 197.93M |
June 30, 2014 | 99.40M |
March 31, 2014 | 89.62M |
December 31, 2013 | 96.90M |
September 30, 2013 | 84.97M |
June 30, 2013 | 101.52M |
March 31, 2013 | 70.93M |
December 31, 2012 | 113.75M |
September 30, 2012 | 60.46M |
June 30, 2012 | 86.53M |
March 31, 2012 | 36.17M |
December 31, 2011 | 28.89M |
September 30, 2011 | 16.78M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
500.53M
Minimum
Jun 2019
943.54M
Maximum
Dec 2023
714.12M
Average
751.87M
Median
Mar 2023
Gross Profit (Quarterly) Benchmarks
Novartis AG | 8.754B |
MorphoSys AG | 47.84M |
Illumina Inc | 674.00M |
Biogen Inc | 1.768B |
Pfizer Inc | 6.686B |